Stock SXTC CHINA SXT PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company China SXT Pharmaceuticals, Inc.

Equities

SXTC

VGG2161P1403

Pharmaceuticals

Delayed Nasdaq
Other stock markets
 02:00:00 19/06/2024 am IST 		5-day change 1st Jan Change
1.08 USD +0.94% Intraday chart for China SXT Pharmaceuticals, Inc. -0.91% -72.79%
13/05 China SXT Pharmaceuticals, Inc. announced that it has received $0.75 million in funding from Streeterville Capital, LLC CI
09/05 China SXT Pharmaceuticals, Inc. announced that it expects to receive $0.75 million in funding from Streeterville Capital, LLC CI

Business Summary

China SXT Pharmaceuticals Inc is a China-based pharmaceutical company that focuses on the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces (TCMP). The Company develops, manufactures and sells three types of TCMP products: advanced TCMP, fine TCMP and regular TCMP, and TCM Homologous Supplements (TCMHS) products. The Company sells its TCMP products under three brand names such as Suxuangtang, Hui Chun Tang and Tong Ren Tang. Most of its products are sold on a prescription basis across China.

Number of employees: 78

Sales per Business

USD in Million2022Weight2023Weight Delta
Regular Traditional Chinese Medicine Pieces
35.4 %
1 30.5 % 1 35.4 % -12.09%
Advanced Traditional Chinese Medicine Pieces
33.3 %
1 44.7 % 1 33.3 % -43.52%
Raw Medicinal Materials
25.5 %
- - 1 25.5 % -
Fine Traditional Chinese Medicine Pieces
5.8 %
0 15.4 % 0 5.8 % -71.28%

Sales per region

USD in Million2022Weight2023Weight Delta
China
100.0 %
3 100.0 % 2 100.0 % -24.23%

Managers

Managers TitleAgeSince
Feng Zhou CEO
 Chief Executive Officer 32 04/17/04
Xiaodong Pan DFI
 Director of Finance/CFO - 31/22/31
Peter Chan IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Feng Zhou CEO
 Chief Executive Officer 32 04/17/04
Jun Zheng BRD
 Director/Board Member 47 31/18/31
Xiaodong Ji BRD
 Director/Board Member 54 22/21/22
Tong Liu BRD
 Director/Board Member - 10/22/10
Songfan He BRD
 Director/Board Member - 10/22/10

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 565,533 423,829 ( 74.94 %) 0 74.94 %

Shareholders

NameEquities%Valuation
AVANZA BANK HOLDING AB
5.425 %
30,679 5.425 % 32 213 $
Feng Zhou
0.7515 %
4,250 0.7515 % 4 463 $
Acadian Asset Management LLC
0.4879 %
2,759 0.4879 % 2 897 $
Qube Research & Technologies Ltd. (France)
0.0182 %
103 0.0182 % 108 $
UBS Group AG (13f Subfiler)
0.001415 %
8 0.001415 % 8 $
BANQUE CANTONALE VAUDOISE
0.000177 %
1 0.000177 % 1 $
The Lind Partners LLC
0.000000 %
0 0.000000 % - $

Company contact information

China Sxt Pharmaceuticals, Inc.

178 Taidong North Road

86298290, Taizhou

+86 523 8629 8290

http://www.sxtchina.com
address China SXT Pharmaceuticals, Inc.(SXTC)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
CHINA SXT PHARMACEUTICALS, INC. Stock China SXT Pharmaceuticals, Inc.
-72.79% 786K
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+52.93% 803B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+40.98% 629B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.08% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.40% 324B
ABBVIE INC. Stock AbbVie Inc.
+10.58% 303B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.42% 244B
ROCHE HOLDING AG Stock Roche Holding AG
+2.17% 226B
NOVARTIS AG Stock Novartis AG
+10.66% 215B
AMGEN INC. Stock Amgen Inc.
+6.24% 164B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. SXTC Stock
  4. Company China SXT Pharmaceuticals, Inc.